Correct, the question I'm pondering now concerns if It's cheaper for TEVA and other Big Pharm to buy MSB lock stock, get all the IP/Pipeline/etc rather than fund the trials?
setting the record straight, page-17
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.053(3.76%) |
Mkt cap ! $1.621B | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.45 | $1.40 | $2.583M | 1.815M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 14993 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 428606 | 24 |
View Market Depth
| Last trade - 12.02pm 11/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |